DK2748147T3 - Substitueret 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinolin-4-carboxamider til antimalaria-terapier - Google Patents

Substitueret 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinolin-4-carboxamider til antimalaria-terapier

Info

Publication number
DK2748147T3
DK2748147T3 DK12772470.6T DK12772470T DK2748147T3 DK 2748147 T3 DK2748147 T3 DK 2748147T3 DK 12772470 T DK12772470 T DK 12772470T DK 2748147 T3 DK2748147 T3 DK 2748147T3
Authority
DK
Denmark
Prior art keywords
tetrahydroisoquinoline
carboxamides
heteroaryl
oxo
phenyl
Prior art date
Application number
DK12772470.6T
Other languages
Danish (da)
English (en)
Inventor
Rodney Kiplin Guy
Fangyi Zhu
Wendyam Armand Guiguemde
David Floyd
Spencer Knapp
Philip Stein
Steve Castro
Original Assignee
St Jude Children's Res Hospital
Medicines For Malaria Venture Mmv
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Children's Res Hospital, Medicines For Malaria Venture Mmv, Univ Rutgers filed Critical St Jude Children's Res Hospital
Application granted granted Critical
Publication of DK2748147T3 publication Critical patent/DK2748147T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK12772470.6T 2011-08-25 2012-08-24 Substitueret 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinolin-4-carboxamider til antimalaria-terapier DK2748147T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161527594P 2011-08-25 2011-08-25
PCT/IB2012/054305 WO2013027196A1 (en) 2011-08-25 2012-08-24 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies

Publications (1)

Publication Number Publication Date
DK2748147T3 true DK2748147T3 (da) 2017-11-13

Family

ID=47018313

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12772470.6T DK2748147T3 (da) 2011-08-25 2012-08-24 Substitueret 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinolin-4-carboxamider til antimalaria-terapier

Country Status (19)

Country Link
US (1) US9416124B2 (OSRAM)
EP (1) EP2748147B1 (OSRAM)
JP (1) JP6035334B2 (OSRAM)
CN (1) CN103930404B (OSRAM)
BR (1) BR112014004437B1 (OSRAM)
CA (1) CA2846507C (OSRAM)
CY (1) CY1119748T1 (OSRAM)
DK (1) DK2748147T3 (OSRAM)
ES (1) ES2644082T3 (OSRAM)
HR (1) HRP20171567T1 (OSRAM)
HU (1) HUE034721T2 (OSRAM)
LT (1) LT2748147T (OSRAM)
ME (1) ME02908B (OSRAM)
PL (1) PL2748147T3 (OSRAM)
PT (1) PT2748147T (OSRAM)
RS (1) RS56544B1 (OSRAM)
SI (1) SI2748147T1 (OSRAM)
SM (1) SMT201700528T1 (OSRAM)
WO (1) WO2013027196A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886225A (zh) * 2017-08-21 2020-11-03 纳维根公司 Arf6抑制剂及相关方法
EP3892332A1 (en) * 2020-04-09 2021-10-13 University Of Kentucky Research Foundation New anti-malarial agents
MX2023012143A (es) 2021-04-15 2024-01-11 Rdp Pharma Ag Derivados de isoquinolina para usarse como agentes antivirales y antitumorales.
EP4074314A1 (en) 2021-04-15 2022-10-19 Valdospan GmbH Isoquinoline derivatives for use as antiviral and antitumour agents
AU2023363824A1 (en) 2022-10-17 2025-04-17 Rdp Pharma Ag Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409938A (en) * 1994-02-14 1995-04-25 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
US5639761A (en) 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
US20050124614A1 (en) 2002-07-03 2005-06-09 Axys Pharmaceuticals, Inc. 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis
DE10237722A1 (de) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
DE10312963A1 (de) 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
PE20061351A1 (es) * 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
RU2302417C1 (ru) * 2006-03-14 2007-07-10 Иващенко Андрей Александрович 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
EP2282996A1 (en) * 2008-05-19 2011-02-16 Actelion Pharmaceuticals Ltd. Tetrahydroisoquinolines as antimalarial agents
GB0820856D0 (en) 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication

Also Published As

Publication number Publication date
HUE034721T2 (hu) 2018-02-28
EP2748147A1 (en) 2014-07-02
BR112014004437B1 (pt) 2021-12-14
CN103930404B (zh) 2016-08-24
HRP20171567T1 (hr) 2017-11-17
ES2644082T3 (es) 2017-11-27
WO2013027196A1 (en) 2013-02-28
SI2748147T1 (sl) 2017-11-30
PL2748147T3 (pl) 2018-01-31
US20140235593A1 (en) 2014-08-21
CA2846507A1 (en) 2013-02-28
PT2748147T (pt) 2017-11-14
JP2014524464A (ja) 2014-09-22
CN103930404A (zh) 2014-07-16
SMT201700528T1 (it) 2018-01-11
RS56544B1 (sr) 2018-02-28
BR112014004437A8 (pt) 2018-01-23
CA2846507C (en) 2020-03-10
JP6035334B2 (ja) 2016-11-30
US9416124B2 (en) 2016-08-16
HK1199443A1 (en) 2015-07-03
CY1119748T1 (el) 2018-06-27
BR112014004437A2 (pt) 2017-03-28
LT2748147T (lt) 2017-10-25
ME02908B (me) 2018-10-20
WO2013027196A9 (en) 2013-04-18
EP2748147B1 (en) 2017-08-02

Similar Documents

Publication Publication Date Title
BR112013024491A2 (pt) neuroestimulador.
BR112015004233A2 (pt) inalador.
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
EP2709645A4 (en) ENHANCED PEPTIDE PHARMACEUTICAL AGENTS
BR112015004230A2 (pt) inalador.
LT2502622T (lt) Farmacinė vaisto forma, apimanti inozitolį
EP2736379A4 (en) IMPROVEMENTS IN CASTERS
EP2914254A4 (en) COMBINATION THERAPIES
BR112014009319A2 (pt) compostos farmacêuticos
BR112013030897A2 (pt) composição.
FR2986872B1 (fr) .
IT1404076B1 (it) Apparecchiatura di aspirazione.
ITRM20120601A1 (it) Formatore di spalla.
ITMI20121619A1 (it) Proiettore.
PL2748147T3 (pl) Podstawione 2-alkilo-1-okso-n-fenylo-3-heteroarylo-1,2,3,4- tetrahydroizochinolino-4-karboksamidy do terapii przeciwmalarycznych
FR2978994B1 (fr) .
DK2500470T3 (da) Hoved-arbejdsvogn
BR112014027645A2 (pt) 5-halogenopirazol bifenilcarboxamidas.
BR112014024938A2 (pt) agitador horizontal.
BR112013019806A2 (pt) derivado de tetrahidroisoquinolina.
ES2397885B1 (es) Derivados de colismicina.
FR2980994B1 (fr) Prehenseur multi-plaquettes.
ES1074539Y (es) Mandil.
ES1074780Y (es) Columna-luminaria.
FI9365U1 (fi) Halkaisulaite